- The lifesaving potential of cordblood Around 1,400 people in the UK receive a potentially lifesaving stem cell transplant from an unrelated donor each year. But there…
- Improving the donor experience With the opening of Anthony Nolan’s Cell Collection Centre in September, we can now work towards more life-saving transplants happening…
- Cutting edge treatment In 2022, at 13 years old, Alyssa became the first patient in the world to be treated with a new therapy using cutting edge genetic technology to…
- Improving transplant equity A stem cell transplant can be a lifesaving treatment for someone with a blood cancer or blood disorder. But we know that not everyone has…
- The potential of transplant data Stem cell transplants can save lives, but we have so much more to understand about how they work and how we can improve them so that…
- Last week, new UK-wide regulations aiming to get personalised treatments like CAR-T to patients faster became active. The Human Medicines (Amendment) (Modular Manufacture…
- Anthony Nolan is proud to announce the launch of SEQoL, which stands for Scaled collection of socioEconomic and Quality of Life data from patients undergoing stem cell transplants…
- Anthony Nolan is proud to facilitate three stem cell transplants a day. Though they give patients a vital second chance of life, they can also lead to severe post-transplant…
- What is HLA? The HLA family of genes encode proteins that form part of our immune system and are critical in allowing it to distinguish between ‘self’ (our own cells)…
- Daniel Gibson, Anthony Nolan’s Assistant Director of the Cell and Gene Therapy Service, talks about the enormous potential of cord blood as a starting material in research to help…
This page has been auto translated by Google Translate. Confirm any health information with your own medical team before acting upon it. All printed materials and PDFs are available in English only.